Equitable Holdings Inc. Increases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Equitable Holdings Inc. increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,024 shares of the healthcare conglomerate’s stock after buying an additional 63 shares during the quarter. Equitable Holdings Inc.’s holdings in UnitedHealth Group were worth $2,814,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Accel Wealth Management purchased a new stake in UnitedHealth Group during the fourth quarter valued at about $26,000. Front Row Advisors LLC raised its holdings in UnitedHealth Group by 288.0% in the third quarter. Front Row Advisors LLC now owns 97 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 72 shares during the period. Knuff & Co LLC grew its stake in UnitedHealth Group by 666.7% during the third quarter. Knuff & Co LLC now owns 115 shares of the healthcare conglomerate’s stock worth $36,000 after buying an additional 100 shares during the period. Ossiam increased its position in shares of UnitedHealth Group by 42.5% in the third quarter. Ossiam now owns 124 shares of the healthcare conglomerate’s stock worth $39,000 after acquiring an additional 37 shares in the last quarter. Finally, Costello Asset Management INC raised its stake in shares of UnitedHealth Group by 500.0% in the 4th quarter. Costello Asset Management INC now owns 120 shares of the healthcare conglomerate’s stock valued at $42,000 after acquiring an additional 100 shares during the period. 86.03% of the stock is currently owned by hedge funds and other institutional investors.

Several analysts recently issued reports on UNH shares. Barclays reiterated a “buy” rating and issued a $405.00 price target on shares of UnitedHealth Group in a report on Sunday, January 17th. BMO Capital Markets increased their target price on UnitedHealth Group from $385.00 to $395.00 and gave the company a “market perform” rating in a research note on Wednesday, December 2nd. They noted that the move was a valuation call. Bank of America reissued a “buy” rating and set a $415.00 price target on shares of UnitedHealth Group in a research report on Thursday, January 21st. Stephens increased their price objective on shares of UnitedHealth Group from $355.00 to $380.00 and gave the company an “overweight” rating in a research report on Wednesday, December 2nd. Finally, Morgan Stanley upped their target price on shares of UnitedHealth Group from $371.00 to $454.00 and gave the company an “overweight” rating in a research note on Wednesday, December 2nd. Five investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $387.82.

In related news, CAO Thomas E. Roos sold 619 shares of the business’s stock in a transaction dated Tuesday, February 9th. The shares were sold at an average price of $323.90, for a total transaction of $200,494.10. Following the completion of the sale, the chief accounting officer now owns 31,908 shares of the company’s stock, valued at approximately $10,335,001.20. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Marianne D. Short sold 9,681 shares of the business’s stock in a transaction dated Tuesday, December 29th. The shares were sold at an average price of $348.00, for a total transaction of $3,368,988.00. Following the sale, the executive vice president now directly owns 167,202 shares of the company’s stock, valued at approximately $58,186,296. The disclosure for this sale can be found here. Over the last three months, insiders have sold 37,293 shares of company stock worth $12,886,401. Corporate insiders own 0.80% of the company’s stock.

Shares of UNH stock opened at $327.64 on Tuesday. The stock has a market capitalization of $310.87 billion, a price-to-earnings ratio of 18.82, a PEG ratio of 1.55 and a beta of 0.74. UnitedHealth Group Incorporated has a one year low of $187.72 and a one year high of $367.95. The company’s 50-day simple moving average is $341.25 and its 200-day simple moving average is $330.10. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.82 and a current ratio of 0.82.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, January 19th. The healthcare conglomerate reported $2.52 EPS for the quarter, topping analysts’ consensus estimates of $2.39 by $0.13. The company had revenue of $65.47 billion for the quarter, compared to the consensus estimate of $64.98 billion. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. UnitedHealth Group’s quarterly revenue was up 7.5% compared to the same quarter last year. During the same quarter last year, the business posted $3.90 EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 16.75 EPS for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.

Featured Story: CD Ladder

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.